The Inspire Sleep Apnea Implant is a medical device that is implanted into the body for the treating snoring and obstructive sleep apnea (OSA) syndrome.
Obstructive ANTI SNORING Syndrome
Obstructive anti snoring syndrome is really a disease caused by relapsing episodes of sleep apnea. That is a condition where breathing stops for more than 10 seconds, during which oxygen saturation in the blood is reduced by a lot more than 4%.
OSA syndrome occurs during sleep, once the muscles of upper airways relax, evoking the obstruction of the respiratory system. This leads to deterioration of blood oxygenation and provokes short unconscious wake-up episodes through the entire night. An unhealthy pattern of sleep places pressure on the body, causing increased blood pressure and development of severe diseases. The diseases caused by OSA could be physical, such as for example hypertension, myocardium infarction and stroke. They might also be mental, including depression, chronic fatigue syndrome, loss of memory and concentration.
Before any treatment, a sleep study or perhaps a polysomnography is necessary. The polysomnography calculates the apnea index, which is the frequency of apnea episodes during 1 hour of sleep and determines the severity of the condition. The apnea index is known as significant if there are a lot more than 20 apnea episodes per hour, regardless of the presence or absence of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy isn’t for everyone as many folks think it is uncomfortable to sleep with the mask on the face and the machine itself can be loud, especially as it commonly sits close to the head. Only 25% of patients may use CPAP-therapy for an extended period of time.
Therefore, recently Inspire Medical Systems Inc. has think of a very effective solution with the Inspire Sleep Apnea Implant.
How The Inspire Sleep Apnea Implant Works
The Inspire ANTI SNORING Implant is a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately 10 years.
The main unit of the device is placed under the skin, on the front right side of the chest also it monitors the phase of breathing. Another electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens top of the airways and allows the tongue to stand out, and helps keep the airways open during sleep.
In addition to the two electrodes, this device also includes a handy small remote switch, that actually turns on these devices before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating through the active phase of the day, whenever a person needs physiological narrowing of the larynx and tongue movements for these procedures.
The individual may feel light involuntary contractions of the larynx, or tongue movements during initial use of these devices. These movements do not cause pain, instead just a minor discomfort. These unpleasant effects disappear following the first few uses of the device.
Generally, the implant should be checked 1 or 2 2 times each year. However, according to the situation, an Inspire therapy-trained doctor may consult patients more or less often.
The Inspire ANTI SNORING Implant is only ideal for:
Patients who are a lot more than 22 years old.
Patients who’ve been diagnosed with moderate or severe obstructive anti snoring syndrome.
Patients having an apnea index in the range of 20 to 65.
Patients who are uncomfortable with using CPAP therapy or did not have the desired effect.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
A person with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire Sleep Apnea Implant may potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive anti snoring syndrome. A report by Dr. Ryan J. et al. has shown that after implantation of the Inspire ANTI SNORING Implant, snoring is greatly decreased. ufa A share of “no” or “soft” snoring changed from 22% at start of the treatment to 88% at 12 months and 91% at two years following the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the analysis reported a nightly use of this therapy for five years. Therefore, it really is evident that method is impressive and easy to use!